Immunomodulatory and antitumour effects of abnormal Savda Munziq on S180 tumour-bearing mice
Ainiwaer Aikemu(Xinjiang Medical University), Nicholas Moore(American Sports Medicine Institute)
Cited by 22
Related Papers
The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosis
|Current Medical Research and Opinion|2023|7